Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Incannex Healthcare Inc. - Common Stock (NQ: IXHL ) 1.880 +0.100 (+5.62%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Incannex Healthcare Inc. - Common Stock < Previous 1 2 3 4 5 6 7 8 Next > 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 06, 2023 Via Benzinga Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues July 01, 2023 Our Psychedelic Drug Stocks Index, which consists of the 6 largest psychedelic compound-based research & development companies, was up 3.4% this week, up 7.1% in June, up 6.3% in May, and is now up... Via Talk Markets Incannex appoints principal investigators for pivotal IHL-42X trial June 19, 2023 Incannex appoints principal investigators for pivotal IHL-42X trial Via News Direct Exposures Product Safety Incannex appoints principal investigators for pivotal IHL-42X trial June 19, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has appointed two highly experienced lead principal investigators for its Phase 2/3 clinical trial of IHL-42X,... Via TheNewswire.com Exposures Product Safety Why Incannex Healthcare Shares Are Gaining Today March 15, 2023 Via Benzinga Incannex Healthcare Has World's Largest Pipeline Of Psychedelic Products March 14, 2023 Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. Via Talk Markets Upward Trend In Major Psychedelic Compound-Based Research & Development Stocks Continue June 17, 2023 There are 6 constituents in our munKNEE Psychedelic Drug Stocks Index and 5 of them advanced this week and are now all up MTD. Via Talk Markets Major Psychedelic Compound-Based Research & Development Stocks: June Update June 10, 2023 Psychedelic Drug Stocks Index has been revamped with the removal of Cybin (CYBN) which has dropped below $100M in market capitalization leaving 6 constituents in the Index Via Talk Markets Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More June 06, 2023 Major Investor Commits $30 Million To Psychedelics Funding Via Benzinga Why A National Cannabis Organization Sacked Half Its Staff, CEO Turnovers And More Exec Changes June 05, 2023 NCIA Sacks Half Of Its Team To Increase Financial Strength Via Benzinga May Summary Of Largest Psychedelic Compound-Based Drug Stock Performances June 01, 2023 Only two of the seven largest psychedelic compound-based drug stocks tracked, advanced in May. Via Talk Markets Incannex welcomes world-leading psychedelics experts to advisory board June 01, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group... Via TheNewswire.com Incannex welcomes world-leading psychedelics experts to advisory board June 01, 2023 Incannex welcomes world-leading psychedelics experts to advisory board Via News Direct Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More May 23, 2023 Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application... Via Benzinga Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary May 16, 2023 Biotech giant Incannex Healthcare Ltd (NASDAQ: IXHL) shared a business presentation of its newly formed psychedelic-assisted therapies subsidiary company, Psychennex Pty Ltd. Via Benzinga Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More May 08, 2023 EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations Via Benzinga Incannex Stock Trading Higher On Entering A Lease For First Psychedelic-Assisted Psychotherapy Clinic May 05, 2023 Incannex Healthcare Ltd (NASDAQ: IXHL) (ASX:IHL) announced that its subsidiary company, Clarion Clinics Group Pty Ltd, has entered a lease for riverfront premises in Abbottsford, Melbourne. Via Benzinga Incannex readying for Phase 2 clinical trial of anti-inflammatory drug IHL-675A May 03, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief medical officer Dr Mark Bleakley speaks with Proactive soon after announcing final results for a Phase 1 clinical trial to assess pharmacokinetics... Via TheNewswire.com Incannex readying for Phase 2 clinical trial of anti-inflammatory drug IHL-675A May 03, 2023 Incannex readying for Phase 2 clinical trial of anti-inflammatory drug IHL-675A Via News Direct Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More May 01, 2023 Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued Via Benzinga April Psychedelic Drug Stocks Recap: The Ups And Downs April 30, 2023 Via Talk Markets New Clinical MDMA And Psilocybin Batches Head To Flourishing Psychedelics Market April 25, 2023 Psychedelics developer PharmAla Biotech continues to provide its Good Manufacturing Practices (GMP)-compliant psychedelics to Australian-based businesses developing clinical trials and, soon, actual... Via Benzinga Largest Psychedelic Stocks -3.4% In March April 02, 2023 The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts. Via Talk Markets Cannabis Category Performances Ranged From +8.6% To -7.0% This Week March 25, 2023 The 5 categories in the cannabis sector perform quite differently from each other and this week was a prime example. Via Talk Markets Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered Via Benzinga Incannex Healthcare Prepares To Launch Psychedelics Clinics Via New Subsidiary March 17, 2023 Australia-based biopharma giant Incannex Healthcare Ltd. (NASDAQ: IXHL) has plans to commercialize its psychedelic-assisted psychotherapy business through a new subsidiary venture under the leadership... Via Benzinga Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder March 15, 2023 Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 15, 2023 Via Benzinga Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 15, 2023 Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Via Benzinga All 5 Cannabis Categories Down Last Week; Only 1 Is UP YTD March 12, 2023 The 5 categories in the cannabis sector perform quite differently from each other. Only 1 is up YTD. Via Talk Markets < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.